A Study on the Immune Response and Safety of the Shingles Vaccine and the Influenza Vaccine When Either is Given to Healthy Adults at the Same Time or Following a COVID-19 Booster Vaccine
Clinical trial NCT05047770 · COMPLETED
Trial details
- NCT number
- NCT05047770
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-07
- Primary completion
- 2022-08-29
- Enrollment
- 2013
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.